CDC42
protein-codingcell division cycle 42, the group of Rho family GTPases
Gene summary
The protein encoded by this gene is a small GTPase of the Rho-subfamily, which regulates signaling pathways that control diverse cellular functions including cell morphology, migration, endocytosis and cell cycle progression. This protein is highly similar to Saccharomyces cerevisiae Cdc 42, and is able to complement the yeast cdc42-1 mutant. The product of oncogene Dbl was reported to specifically catalyze the dissociation of GDP from this protein. This protein could regulate actin polymerization through its direct binding to Neural Wiskott-Aldrich syndrome protein (N-WASP), which subsequently activates Arp2/3 complex. Alternative splicing of this gene results in multiple transcript variants. Pseudogenes of this gene have been identified on chromosomes 3, 4, 5, 7, 8 and 20. [provided by RefSeq, Apr 2013]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~48.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0014757
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0014757
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0014757
Submitter: ClinGen
CDC42 was first reported in relation to autosomal dominant macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome (sometimes known as Takenouchi-Kosaki syndrome) in 2015 (Takenouchi T, et al., 2015, PMID: 26386261). CDC42, a master regulator of actin cytoskeleton and major node in intracellular signaling, is associated with a heterogeneous set of developmental and multi-system phenotypes, demonstrating the critical requirement of proper CDC42 function in a large array of developmental processes. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Patients have a broad spectrum of anomalies; core clinical features include defective growth, intellectual disability, facial dysmorphism, hearing/vision problems, cardiac malformations, immune, hematologic, and lymphatic abnormalities, and brain malformations. Nine unique missense variants have been reported in this gene in at least 9 probands in 2 publications (PMIDs: 26386261 and 29394990). Segregation was observed in one family (Family 30153 in PMID: 29394990), all others were de novo occurrences. This gene-disease relationship is supported by its interaction with WAS (PMID: 8643625) and multiple model systems with partial recapitulation of human disease (PMIDs: 29394990, 16510873, 20139097, 22387309). In summary CDC42 is definitively associated with autosomal dominant macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome.
Inheritance Pattern: AD
Disease ID:MONDO:0014757
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Craniofacial; Genitourinary; Hematologic; Musculoskeletal; Neurologic; Renal
Intervention: Cardiovascular
Rationale: Individuals have been described with congenital heart anomalies, and awareness may enable early diagnosis and management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CDC42 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001791.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 34 | 3 | 38 | ||
| missense | 10 | 16 | 36 | 62 | ||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 2 | |||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 10 | 17 | 40 | 34 | 3 | 104 |
Highest pathogenic variant AF is 0.0000013762314
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001782.1 | 5 | MANE Select | |
| Ensembl | ENSP00000499457.1 | 5 | MANE Select | |
| RefSeq | NP_001034891.1 | 5 | Standard | |
| RefSeq | NP_426359.1 | 5 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| cdc42 | Danio rerio | Structure: photoreceptor cell Quality: absent abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Focal adhesion - Homo sapiens (human)
- T cell receptor signaling pathway - Homo sapiens (human)
- Fc gamma R-mediated phagocytosis - Homo sapiens (human)
- Salmonella infection - Homo sapiens (human)
- Renal cell carcinoma - Homo sapiens (human)
Biological Process
- sprouting angiogenesis
- protein phosphorylation
- endocytosis
- phagocytosis, engulfment
- actin filament organization
Molecular Function
- GTPase activity
- protein serine/threonine kinase activity
- protein binding
- GTP binding
- protein kinase binding
Cellular Component
- Golgi membrane
- cytoplasm
- endoplasmic reticulum membrane
- centrosome
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000344548
- Coding exons
- 5
- Length
- 40318
- Individuals with no LoFs
- 125677
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 2
- Defined
- 125679
- p
- 0.00000796
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 3.04 | 17 | 104 | 0.163 | 0.00000544 | 1229 |
| Missense (PolyPhen) | 1 | 29.982 | 0.033353 | 378 | ||
| Synonymous | -0.608 | 45 | 40.1 | 1.12 | 0.00000222 | 388 |
| Loss of Function | 2.55 | 1 | 9.47 | 0.106 | 4.99e-7 | 115 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.0000089 | 0.0000088 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plasma membrane-associated small GTPase which cycles between an active GTP-bound and an inactive GDP-bound state. In active state binds to a variety of effector proteins to regulate cellular responses. Involved in epithelial cell polarization processes. Regulates the bipolar attachment of spindle microtubules to kinetochores before chromosome congression in metaphase. Plays a role in the extension and maintenance of the formation of thin, actin-rich surface projections called filopodia. Mediates CDC42-dependent cell migration. Required for DOCK10-mediated spine formation in Purkinje cells and hippocampal neurons. Facilitates filopodia formation upon DOCK11-activation (By similarity). Also plays a role in phagocytosis through organization of the F-actin cytoskeleton associated with forming phagocytic cups. {ECO:0000250|UniProtKB:P60766, ECO:0000269|PubMed:14978216, ECO:0000269|PubMed:15642749, ECO:0000269|PubMed:17038317, ECO:0000269|PubMed:26465210}.;
- Disease
- DISEASE: Takenouchi-Kosaki syndrome (TKS) [MIM:616737]: A syndrome characterized by macrothrombocytopenia, lymphedema, mental retardation, developmental delay, and distinctive facial features. {ECO:0000269|PubMed:26386261, ECO:0000269|PubMed:26708094}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.914
Intolerance Scores
- LoFtool
- 0.282
- RVIS EVS
- -0.1
- RVIS percentile EVS
- 46.2
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.926
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |